Canterbury Health Laboratories (CHL), Christchurch New Zealand
Canterbury Health Laboratories (CHL) is one of two tertiary level reference and teaching laboratories within New Zealand with capability and experience in providing a range of services. CHL employs over 400 staff, including experienced teams of medical laboratory scientists, technicians, scientific officers and clinicians, with expertise across all disciplines. Research and development is supported.
The Immunology Section within CHL provides a nationwide therapeutic drug monitoring service to gastroenterologists and rheumatologists for Infliximab, Adalimumab and Etanercept. The tests provided include drug levels for infliximab, adalimumab, etanercept and ADA for infliximab, adalimumab and etanercept.
Drug levels are measured using in-house validated ELISA. ADA are measured using HMSA method, and neutralising ADA determined using an in-house validated competitive ligand binding assay. The techniques used are published.
Contact: Paula Keating@cdhb.health.nz, phone: +64 3 3640413